proline has been researched along with Parkinson Disease in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (15.63) | 18.7374 |
1990's | 2 (6.25) | 18.2507 |
2000's | 13 (40.63) | 29.6817 |
2010's | 10 (31.25) | 24.3611 |
2020's | 2 (6.25) | 2.80 |
Authors | Studies |
---|---|
Julku, UH; Kilpeläinen, T; Myöhänen, TT; Svarcbahs, R | 1 |
Cui, H; Erlandsson, A; Falk, A; Jäntti, M; Kukkonen, JP; Myöhänen, T; Rinne, MK; Rostami, J | 1 |
Andreas, LB; Baker, JD; Becker, S; Blair, LJ; Favretto, F; Flores, D; Strohäker, T; Zweckstetter, M | 1 |
Bindoff, LA; Haugarvoll, K | 1 |
Huttunen, HJ; Myöhänen, TT; Savolainen, MH; Yan, X | 1 |
An, R; Chen, Y; Tian, S; Xu, Y; Yang, X; Zhao, Q; Zheng, J | 1 |
Cheng, L; Li, JY; Li, NN; Lu, ZJ; Peng, R; Sun, XY; Tan, EK; Wang, L; Zhang, JH | 1 |
Julku, UH; Myöhänen, TT; Svarcbahs, R | 1 |
Ross, OA; Tan, EK; Tan, LC; Tang, M; Wu, RM; Wu, YR; Zhao, Y | 1 |
An, X; Burgunder, JM; Chen, W; Gou, Y; Mao, X; Peng, R; Wang, Y; Wu, Y; Xu, Y; Yuan, G; Zhang, J; Zhang, Z | 1 |
Bax, A; Bodner, CR; Dobson, CM; Maltsev, AS | 1 |
Guo, JF; Pan, Q; Sun, QY; Tang, BS; Wang, L; Xia, K; Yao, LY; Yu, RH; Zuo, X | 1 |
Cornejo Castro, EM; Fog, K; Jensen, PH; Kahle, PJ; Rannikko, EH; Shaik, JH; Vesterager, LB; Weber, SS | 1 |
Augustin, J; Ayrignac, X; Campion, D; Clanet, M; Coutant, S; Defebvre, L; Frébourg, T; Guyant-Maréchal, L; Hannequin, D; Krystkowiak, P; Labauge, P; Le Ber, I; Lefaucheur, R; Legallic, S; Maltête, D; Martinaud, O; Nicolas, G; Pariente, J; Pottier, C; Rousseau, S; Rovelet-Lecrux, A; Vaschalde, Y | 1 |
Bussell, R; Eliezer, D | 1 |
Frasier, M; Haas, C; Kahle, P; Lee, JM; Magnuson, D; McCarthy, L; Walzer, M; Wolozin, B | 1 |
Butterfield, DA; Calabrese, V; Frasier, M; Poon, HF; Shreve, N; Wolozin, B | 1 |
Kobayashi, N; Ochiai, S; Sode, K; Usuzaka, E | 1 |
Aasly, JO; Farrer, MJ; Pielsticker, L; Ross, OA; Toft, M | 1 |
Allen-Auerbach, M; Doostzadeh, J; Langston, JW; Schüle, B; Tetrud, JW | 1 |
Chen, S; Deng, X; Ding, X; Dong, H; Li, W; Li, X; Ma, G; Wu, T; Yao, J; Zeng, Y; Zhang, X | 1 |
Annesi, F; Annesi, G; Carrideo, S; Cirò Candiano, IC; Civitelli, D; Condino, F; De Marco, EV; Messina, D; Morelli, M; Nicoletti, G; Novellino, F; Provenzano, G; Quattrone, A; Rocca, FE; Tarantino, P | 1 |
Bird, TD; Griffith, A; Leis, BC; Leverenz, JB; Mata, IF; Roberts, JW; Samii, A; Schellenberg, GD; Schneer, SH; Sidransky, E; Tsuang, D; Zabetian, CP | 1 |
Bock, H; Hilbig, A; Jardim, LB; Michelin-Tirelli, K; Rieder, CR; Saraiva-Pereira, ML; Socal, MP | 1 |
Blanchard, PJ; Falkous, G; Ishiura, S; Mantle, D; Perry, EK | 1 |
Epplen, JT; Graeber, M; Kösel, S; Krüger, R; Kuhn, W; Müller, T; Przuntek, H; Riess, O; Schöls, L; Woitalla, D | 1 |
Conway, KA; Harper, JD; Lansbury, PT | 1 |
Amsler, U; Cuénod, M; Perschak, H; Siegfried, J; Vischer, A | 1 |
Chase, TN; Lipton, MA; Morris, CE; Woods, AC | 1 |
Barbeau, A; Kastin, AJ | 1 |
Beasley, BL; Boehme, DH; Chambers, RA; Hare, TA; Vogel, WH | 1 |
Brune, GG; Pflughaupt, KW | 1 |
1 review(s) available for proline and Parkinson Disease
Article | Year |
---|---|
Mutational scanning of the CHCHD2 gene in Han Chinese patients with Parkinson's disease and meta-analysis of the literature.
Topics: Adult; Aged; Asian People; DNA Mutational Analysis; DNA-Binding Proteins; Genetic Association Studies; Genotype; Humans; Leucine; Middle Aged; Mitochondrial Proteins; Mutation; Parkinson Disease; Proline; Transcription Factors | 2016 |
31 other study(ies) available for proline and Parkinson Disease
Article | Year |
---|---|
Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease.
Topics: Aging; Alanine; alpha-Synuclein; Amino Acid Substitution; Animals; Behavior, Animal; Disease Models, Animal; Dopaminergic Neurons; Humans; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation, Missense; Parkinson Disease; Proline; Threonine | 2019 |
Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.
Topics: alpha-Synuclein; Astrocytes; Autophagy; Cell Line, Tumor; Cells, Cultured; Disease Progression; Humans; Neurons; Parkinson Disease; Proline; Prolyl Oligopeptidases; Serine Proteinase Inhibitors | 2020 |
Catalysis of proline isomerization and molecular chaperone activity in a tug-of-war.
Topics: alpha-Synuclein; Amyloid; Catalysis; Cyclophilin A; Cyclosporine; Humans; Isomerism; Kinetics; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Chaperones; Parkinson Disease; Proline; Protein Aggregates; Protein Binding; Protein Domains | 2020 |
A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype.
Topics: Adult; Arginine; Heterozygote; Humans; Male; Mutation, Missense; Parkinson Disease; Phenotype; Proline; Tyrosine 3-Monooxygenase | 2011 |
Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.
Topics: alpha-Synuclein; Amino Acid Substitution; Animals; Autophagy; Cell Line, Tumor; Gene Expression Regulation, Enzymologic; Mice; Mutation, Missense; Parkinson Disease; Proline; Prolyl Oligopeptidases; Protein Multimerization; Protein Structure, Tertiary; Serine Endopeptidases | 2015 |
Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Asian People; China; DNA-Binding Proteins; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Leucine; Male; Middle Aged; Mitochondrial Proteins; Mutation; Parkinson Disease; Proline; Risk Factors; Transcription Factors | 2016 |
Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
Topics: alpha-Synuclein; Animals; Brain Chemistry; Endopeptidase K; Forelimb; Genetic Vectors; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neural Pathways; Parkinson Disease; Proline; Prolyl Oligopeptidases; Protease Inhibitors; Serine Endopeptidases; Tyrosine 3-Monooxygenase | 2016 |
Lrrk2 R1628P in non-Chinese Asian races.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Asian People; Female; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Proline; Protein Serine-Threonine Kinases | 2008 |
LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Asian People; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Protein Serine-Threonine Kinases; Young Adult | 2009 |
Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.
Topics: Alanine; alpha-Synuclein; Genetic Variation; Glutamic Acid; Humans; Lysine; Magnetic Resonance Spectroscopy; Mutagenesis, Site-Directed; Parkinson Disease; Peptide Fragments; Phospholipids; Proline; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Solutions; Threonine | 2010 |
Glucocerebrosidase gene L444P mutation is a risk factor for Parkinson's disease in Chinese population.
Topics: Adult; Asian People; Case-Control Studies; Chi-Square Distribution; DNA Mutational Analysis; Female; Glucosylceramidase; Humans; Leucine; Male; Meta-Analysis as Topic; Middle Aged; Mutation; Parkinson Disease; Proline | 2010 |
Loss of DJ-1 protein stability and cytoprotective function by Parkinson's disease-associated proline-158 deletion.
Topics: Amino Acid Sequence; Animals; Cell Line; Disease Models, Animal; Humans; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Mice; Molecular Sequence Data; Multiple System Atrophy; Oncogene Proteins; Parkinson Disease; Peroxiredoxins; Point Mutation; Proline; Protein Deglycase DJ-1; Protein Stability; Protein Structure, Quaternary; Rats; Transfection | 2013 |
Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.
Topics: Adult; Aged; Amino Acid Substitution; Arginine; Basal Ganglia Diseases; Calcinosis; Child; Databases, Genetic; Exome; Female; Humans; Leucine; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurologic Examination; Parkinson Disease; Pedigree; Polymerase Chain Reaction; Proline; Receptor, Platelet-Derived Growth Factor beta; Tomography, X-Ray Computed; Tryptophan | 2013 |
Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein.
Topics: Alanine; alpha-Synuclein; Humans; Lipid Metabolism; Liposomes; Micelles; Mutation, Missense; Nerve Tissue Proteins; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Phosphatidic Acids; Phosphatidylcholines; Proline; Protein Binding; Protein Structure, Secondary; Recombinant Proteins; Synucleins; Threonine | 2004 |
Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
Topics: Age Factors; Alanine; alpha-Synuclein; Amino Acid Substitution; Animals; Antibodies, Monoclonal; Blotting, Western; Brain; Disease Models, Animal; Female; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Movement Disorders; Mutation; Nerve Tissue Proteins; Neurons; Parkinson Disease; Phosphorylation; Proline; Synucleins; tau Proteins | 2005 |
Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Topics: Alanine; alpha-Synuclein; Animals; Brain; Disease Models, Animal; Energy Metabolism; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondrial Proteins; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Proline; Synucleins | 2005 |
Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation.
Topics: alpha-Synuclein; Alzheimer Disease; Amino Acid Sequence; Amyloid; Bone Marrow Cells; Circular Dichroism; DNA; DNA, Complementary; Gene Library; Humans; Light; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Nerve Tissue Proteins; Parkinson Disease; Peptides; Polymerase Chain Reaction; Proline; Protein Binding; Protein Conformation; Protein Engineering; Protein Structure, Secondary; Scattering, Radiation; Synucleins; Time Factors; Ubiquitin-Protein Ligases; Ultraviolet Rays; Valine | 2005 |
Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.
Topics: Adult; Aged; Aged, 80 and over; Asparagine; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Glucosylceramidase; Heterozygote; Humans; Leucine; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Serine | 2006 |
Novel features in a patient homozygous for the L347P mutation in the PINK1 gene.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Homozygote; Humans; Lysine; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Protein Kinases | 2007 |
A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Leucine; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
Topics: Aged; Asparagine; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glucosylceramidase; Humans; Italy; Leucine; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Serine | 2008 |
Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
Topics: Aged; Asparagine; Case-Control Studies; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glucosylceramidase; Humans; Leucine; Lewy Body Disease; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Risk Factors; Serine | 2008 |
Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians.
Topics: Adult; Asparagine; Brazil; Female; Glucosylceramidase; Heterozygote; Humans; Leucine; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Serine | 2009 |
Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Dementia; Female; Humans; Huntington Disease; Lewy Bodies; Male; Parkinson Disease; Proline; Prolyl Oligopeptidases; Serine Endopeptidases; Tissue Distribution | 1996 |
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
Topics: Alanine; alpha-Synuclein; Amino Acid Sequence; Base Sequence; Female; Humans; Male; Nerve Tissue Proteins; Parkinson Disease; Pedigree; Point Mutation; Polymorphism, Single-Stranded Conformational; Proline; Synucleins | 1998 |
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Topics: Alanine; alpha-Synuclein; Amino Acid Sequence; Amyloid; Benzothiazoles; Binding Sites; Brain; Circular Dichroism; Congo Red; Endopeptidases; Humans; Hydrolysis; Immunohistochemistry; Lewy Bodies; Microscopy, Atomic Force; Microscopy, Polarization; Molecular Sequence Data; Mutation, Missense; Nerve Tissue Proteins; Parkinson Disease; Postmortem Changes; Proline; Protein Structure, Secondary; Recombinant Proteins; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Synucleins; Thiazoles; Threonine | 2000 |
Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
Topics: Adult; Aged; Amino Acids; Aspartic Acid; Ethanolamine; Ethanolamines; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease; Proline; Tremor | 1987 |
Hypothalamic releasing factors and Parkinson disease.
Topics: Antiparkinson Agents; Depression, Chemical; Dihydroxyphenylalanine; Drug Therapy, Combination; Glycine; Humans; Leucine; Melanocyte-Stimulating Hormones; Oligopeptides; Parkinson Disease; Pituitary Hormone-Releasing Hormones; Proline; Thyrotropin-Releasing Hormone | 1974 |
Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.
Topics: Administration, Oral; Aged; Amides; Antiparkinson Agents; Dihydroxyphenylalanine; Female; Glycine; Humans; Injections, Intravenous; Leucine; Male; Middle Aged; Movement Disorders; Parkinson Disease; Peptides; Proline | 1972 |
DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with Parkinson's disease before and during treatment with L-DOPA.
Topics: Administration, Oral; Adult; Aged; Amino Acids; Animals; Autoanalysis; Child; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Fasting; Female; Humans; Injections, Intraperitoneal; Male; Methionine; Middle Aged; Parkinson Disease; Proline; Rats; Time Factors | 1973 |
Hypoprolinemia in Parkinsonism: a case report.
Topics: Aged; Amino Acids; Humans; Male; Parkinson Disease; Proline | 1971 |